Regeneron has expanded its research alliance with CytomX Therapeutics, paying $37 million to work on conditionally active bispecifics against two targets…
In an innovative leap for sustainable architecture, researchers at Chalmers University of Technology in Sweden have engineered a groundbreaking, entirely…